IFNA1 and myeloid sarcoma: Recent studies on MS pathophysiology have shown an imbalance of adaptive immunity (T regulator, B cell, cytokine, monocytes, Th1, Th17, Th2 and proinflammatory products) due to abnormalities in over 8000 expressed genes that control immune regulation, including interferon (IFN) signaling.